Schmidt & Clark, LLP | A National Law Firm

Oral Sodium Phosphate (OSP) Products for Bowel Cleansing (marketed as Visicol and OsmoPrep, and oral sodium phosphate products available without a prescription)

FDA Warning Letter Recall Notice On December 12, 2008, the U.S. Food & Drug Administration issued a warning to healthcare professionals titled, “Oral Sodium Phosphate (OSP) Products for Bowel Cleansing (marketed as Visicol and OsmoPrep, and oral sodium phosphate products available without a prescription).”

Included below is a copy of the December warning …

The FDA has become aware of reports of acute phosphate nephropathy, a type of acute kidney injury, associated with the use of oral sodium phosphate products (OSP) for bowel cleansing prior to colonoscopy or other procedures. These products include the prescription products, Visicol and OsmoPrep, and OSPs available over-the-counter without a prescription as laxatives (e.g., Fleet Phospho-soda). In some cases when used for bowel cleansing, these serious adverse events have occurred in patients without identifiable factors that would put them at risk for developing acute kidney injury.

FDA is requiring the manufacturer of Visicol and OsmoPrep, the two OSPs available by prescription only, to add a Boxed Warning to the labeling for these products. FDA is also requiring that the manufacturer develop and implement a risk evaluation and mitigation strategy (REMS), which will include a Medication Guide, to ensure that the benefits of these products outweigh the risk of acute phosphate nephropathy, and to conduct a postmarketing clinical trial to further assess the risk of acute kidney injury with use of these products. FDA recommends, in light of the risk of acute phosphate nephropathy, over-the-counter laxative OSP products should not be used for bowel cleansing. Consumers should only use OSPs for bowel cleansing pursuant to a prescription from a healthcare professional.

Do I Have an Acute Phosphate Nephropathy or Oral Sodium Phosphate Lawsuit?

The Defective Drug and Product Liability Litigation Group at our law firm is an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in Acute Phosphate Nephropathy and Oral Sodium Phosphate lawsuits. We are currently pursuing litigation nationwide and accepting new cases in all 50 states.

If you or a loved one have suffered a serious injury after using Visicol, OsmoPrep, Fleet Phospho-soda or another laxative, you should contact us immediately. You may be entitled to compensation for your injuries and we can help.

Related Content on our Website

Attention Attorneys:  Schmidt & Clark considers a referral from another law firm to be one of the greatest compliments. Our law firm has built a reputation for succsess and accepts a number of case referrals on a regular basis. We do not publish prior verdicts or settlements on our website. If you would like to refer us a case or for us to send you a profile of prior award judgments or average referral fees, please visit the attorney referral section of our website.

Spread the Word ...

If you feel that your family, friends or colleagues would find this page helpful, please share it with them via Facebook, MySpace, Twitter or any of the other popular social networking and/or social bookmarking sites by clicking the button below.

Share/Save/Bookmark

Stay Informed!

If you would like to receive periodic updates regarding new product warnings and recalls, please take a few seconds to sign up for our Email Newsletter or subscribe to our RSS feed.

Toll Free 24 hrs/day (866) 588-0600

Super Lawyers

Million Dollar Advocates Forum

The Best Lawyers in America

Law Dragon 500 - Leading Plaintiff's Lawyers in America


AAJ - American Association for Justice

Lexis Nexis Martindale-Hubbell AV Rating - Peer Review Rated Attorney, Lawyer, Law Firm

People Over Profits

Nationwide Representation - Attorney, Lawyer, Lawsuit, Law Firm, Claim, Case, Suit, Class Action